期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (1)
Background: The coronavirus disease 2019 (COVID-19) pandemic has had a dramatic impact on cancer diagnosis and treatment. Most patients newly diagnose......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (3)
Background: The impact of a faecal immunochemical test-based colorectal cancer (CRC) screening program in terms of patient prognosis could be affected......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (6)
Introduction: Desmoid tumor (DT) of the abdomen is a challenging and rare disease. The level of evidence available to document their treatment is rela......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (11)
Background: Symptoms developing during bowel preparation are major concerns among subjects who refuse the procedure. Aims: We aimed to explore the det......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (1)
Background: Capsule endoscopy (SBCE) has developed a relevant role in patients with established Crohn's Disease (CD). However, evaluation of the impac......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (1)
Background: The prognostic role of spontaneous portosystemic shunts (SPSS) has been poorly investigated. Aims: To evaluate the impact of the presence ......
期刊： DIGESTIVE AND LIVER DISEASE, 2022; 54 (3)
Introduction: In patients with unresectable liver metastases from colorectal cancer (CRCLM), systemic doublet or triplet chemotherapy and targeted the......
